wbi@bwh.harvard.edu

Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade

GSE74385Schmidt et al., 2016
Modality
Expression profiling (microarray)
Sample count
62
Patient count
62
Institution
Department of Neurosurgery, Experimental Neurosurgery, Heidelberg University Hospital
Corresponding author
Christel Herold-Mende
Platform
Illumina HumanHT-12 V4.0 expression beadchip (GPL10558)
Access type
open
Tissue preservation
Not reported
WHO edition
Not reported
Grade breakdown
G1: 20 G2: 14 G3: 28
Sex distribution
Not reported
Age distribution
Not reported
Anatomic location
Not reported
Brain invasion
Not reported
Normal/control tissue
None
WHO grade breakdown availableLarge cohort (top quartile)Primary vs. recurrent annotatedOutcome/survival dataPeer-reviewed
  • Schmidt M, et al. Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade. Oncotarget, 2016. PMID 26894859 · DOI
  • Dunn J, et al. Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma. Cancers, 2020. PMID 33167358 · DOI

Also related: PRJNA300220

Sources

  • GEO
    https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74385
  • PubMed
    https://pubmed.ncbi.nlm.nih.gov/26894859/
  • DOI
    https://doi.org/10.18632/oncotarget.7396
  • PubMed
    https://pubmed.ncbi.nlm.nih.gov/33167358/
  • ncbi.nlm.nih.gov
    https://www.ncbi.nlm.nih.gov/bioproject/PRJNA300220